日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Immunogenicity and safety of heterologous immunisation with Ad5-nCOV in healthy adults aged 60 years and older primed with an inactivated SARS-CoV-2 vaccine (CoronaVac): a phase 4, randomised, observer-blind, non-inferiority trial

在已接种灭活SARS-CoV-2疫苗(CoronaVac)的健康成年人(60岁及以上)中,异源免疫接种Ad5-nCOV的免疫原性和安全性:一项4期随机、观察者盲法、非劣效性试验

Jin, Peng-Fei; Guo, Xi-Ling; Gou, Jin-Bo; Hou, Li-Hua; Song, Zhi-Zhou; Zhu, Tao; Pan, Hong-Xing; Zhu, Jia-Hong; Shi, Feng-Juan; Du, Pan; Huang, Hai-Tao; Liu, Jing-Xian; Zheng, Hui; Wang, Xue; Chen, Yin; Wan, Peng; Wu, Shi-Po; Wang, Xue-Wen; Xu, Xiao-Yu; Yan, Fang-Rong; Li, Jing-Xin; Chen, Wei; Zhu, Feng-Cai

P359 Influence of the nature of immunosuppressive therapy in patients with inflammatory bowel diseases on the level of immunoglobulins G after a Coronavirus Infection

P359 免疫抑制疗法的性质对炎症性肠病患者冠状病毒感染后免疫球蛋白G水平的影响

Zhu, Feng-Cai; Li, Yu-Hua; Guan, Xu-Hua; Hou, Li-Hua; Wang, Wen-Juan; Li, Jing-Xin; Wu, Shi-Po; Wang, Bu-Sen; Wang, Zhao; Wang, Lei; Jia, Si-Yue; Jiang, Hu-Dachuan; Wang, Ling; Jiang, Tao; Hu, Yi; Gou, Jin-Bo; Xu, Sha-Bei; Xu, Jun-Jie; Wang, Xue-Wen; Wang, Wei; Chen, Wei; Butler, James J; Rizlan, Muhammad Raziq Mohammed; Azam, Mohammad T; Campbell, Hilary T; Kennedy, John G; Manel, Boudokhane; Hiba, Ben Ayed; Sarra, Ben Yaacoub; Rym, Bourguiba; Zeineb, Teyeb; Mariem, Ayari; Taieb, Jomni; Imen, Abdelaali; Syrine, Belakhal; Hedi, Dougui Mohamed; Bhimani, Rohan; Lubberts, Bart; Hagemeijer, Noortje; Zhao, John Z; Saengsin, Jirawat; Sato, Go; Waryasz, Gregory R; DiGiovanni, Christopher W; Guss, Daniel; Chinnakannu, Karthikeyan; Abyar, Eildar; McKissack, Haley M; Pinto, Martim; Jha, Aaradhana J; Moraes, Leonardo V; Naranje, Sameer M; Shah, Ashish B; Knyazev, O; Kagramanova, A; Lishchinskaya, A; Noskova, K; Chernova, M; Shkurko, T; Veselov, A; Kulakov, D; Li, I; Parfenov, A

Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial

一项针对18岁及以上健康成年人的随机、双盲、安慰剂对照的II期临床试验,评估了重组5型腺病毒载体COVID-19疫苗的免疫原性和安全性。

Zhu, Feng-Cai; Guan, Xu-Hua; Li, Yu-Hua; Huang, Jian-Ying; Jiang, Tao; Hou, Li-Hua; Li, Jing-Xin; Yang, Bei-Fang; Wang, Ling; Wang, Wen-Juan; Wu, Shi-Po; Wang, Zhao; Wu, Xiao-Hong; Xu, Jun-Jie; Zhang, Zhe; Jia, Si-Yue; Wang, Bu-Sen; Hu, Yi; Liu, Jing-Jing; Zhang, Jun; Qian, Xiao-Ai; Li, Qiong; Pan, Hong-Xing; Jiang, Hu-Dachuan; Deng, Peng; Gou, Jin-Bo; Wang, Xue-Wen; Wang, Xing-Huan; Chen, Wei

Remotely controlled chemomagnetic modulation of targeted neural circuits

远程控制化学磁调制目标神经回路

Siyuan Rao, Ritchie Chen, Ava A LaRocca, Michael G Christiansen, Alexander W Senko, Cindy H Shi, Po-Han Chiang, Georgios Varnavides, Jian Xue, Yang Zhou, Seongjun Park, Ruihua Ding, Junsang Moon, Guoping Feng, Polina Anikeeva